摘要
核小体是真核生物染色质的基本单位,核小体的中部由4种组蛋白(H2A,H2B,H3,H4)各两分子形成八聚体,周围围绕DNA,尾部为组蛋白H1。核小体表面修饰与基因表达调控联系密切。组蛋白乙酰化是其中一种重要的共价修饰,通过招募染色体构型重建复合体引起染色体构型发生改变。染色体构型改变使高度螺旋的染色质变得相对松弛,便于转录因子与DNA结合。使组蛋白乙酰化的主要是组蛋白乙酰转移酶(histone acetyltransferase,HAT)和组蛋白去乙酰化酶抑制剂(histone deacetylase inhibitors,HDACI)。
出处
《感染.炎症.修复》
2009年第3期187-189,共3页
Infection Inflammation Repair
基金
军队医药卫生"十一五"科研基金资助项目(06Z055)
参考文献20
-
1Mahlknecht U, Hoelzer D. Histone aeetylation modifiers in the pathogensis of malignant disease. Mol Med,2000, 6(8):623-644.
-
2Kramer OH, Gottlicher M, Heinzel T. Histone deacetylase as a therapeutic target. Trends Endocrinol Metab,2001, 12(7) 1294-300.
-
3Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene, 2007, 26(37) : 5541-5552.
-
4Budillion A, Bruzzese F, Di Gennaro, et al. Multiple-target drugs: inhibitors of heat shock protein 90 and histone deacetylase. Curr Drug Targets,2005, 6(3):337-351.
-
5周鹏,徐运.神经退行性疾病中的乙酰化内稳态[J].生命的化学,2006,26(6):541-543. 被引量:2
-
6Leng Y, Chuang DM. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate induced excitotoxicity. J Neurosci,2006, 26(28) :7502-7512.
-
7Ren M, Leng Y, Jeong M, et al. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem, 2004, 89(6):1358-1367.
-
8Li Y, Yuan Z, Liu B, et al. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J Trauma, 2008, 65(4):863-870.
-
9Sinn DI, Kim SJ, Chu K,et al. Valproie acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis, 2007, 26 (2) : 464-472.
-
10Kim HJ, Rowe M, Ren M, etal. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther, 2007, 321(3) :892-901.
二级参考文献14
-
1Saha RN et al.Cell Death Differ,2006,13(4):539-550
-
2Marmorstein R et al.Curr Opin Genet Dev,2001,11:155-161
-
3de Ruijter AJ et al.Biochem J,2003,370:737-749
-
4Salminen A et al.Brain Res Mol Brain Res,1998,61:203-206
-
5Rouaux C et al.EMBO J,2003,22(24):6537-6549
-
6Jiang H et al.Hum Mol Genet,2003,12:1-12
-
7Hockly E et al.Proc Natl Acad Sci USA,2003,100(4):2041-2046
-
8Steffan JS et al.Nature,2001,413:739-743
-
9Marambaud P et al.Cell,2003,114:635-645
-
10Nucifora FC Jr et al.Science,2001,291(5512):2423-2428
同被引文献25
-
1Gonzales ER,Chen H,Munuve RM,et al.Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.J Trauma,2008,65(3):554-565.
-
2Shults C,Sailhamer EA,Li Y,et al.Surviving blood loss without fluid resuscitation.J Trauma,2008,64(3):629-640.
-
3Li Y,Liu B,Zhao H,et al.Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.Shock,2009,32(5):517-523.
-
4Alam HB,Shuja F,Butt MU,et al.Surviving blood loss without blood transfusion in a swine poly-trauma model.Surgery,2009,146(2):325-333.
-
5Lin T,Alam HB,Chen H,et al.Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation.Surgery,2006,139 (3):365-376.
-
6Li Y,Liu B,Sailhamer EA,et al.Cell protective mechanism of valproic acid in lethal hemorrhagic shock.Surgery,2008,144(2):217-224.
-
7Butt MU,Sailhamer EA,Li Y,et al.Pharmacologic resuscitation:cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.J Surg Res,2009,156(2):290-296.
-
8Fukudome EY,Kochanek AR,Li Y,et al.Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-Regulated Kinase 1/2.J Surg Res,2010,163(1):118-126.
-
9Gonzales ER,Chen H,Munuve RM,et al.Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones.Shock,2006,25(4):395-401.
-
10Sailhamer EA,Li Y,Smith EJ,et al.Hypoxic "second hit" in leukocytes from trauma patients:modulation of the immune response by histone deacetylase inhibition.Cytokine,2010,49(3):303-311.
引证文献3
-
1刘先奇,白晓东,胡森.组蛋白去乙酰化酶抑制剂抗休克的研究进展[J].感染.炎症.修复,2010,11(3):191-192. 被引量:2
-
2张帆,王晓青,刘皈阳,胡森.应用丙戊酸钠抗休克的研究进展[J].感染.炎症.修复,2012,13(2):127-128.
-
3黄道伟,马志龙,张庆伟,张越,李建其.MGCD0103的合成[J].中国医药工业杂志,2012,43(12):968-970. 被引量:3
二级引证文献5
-
1焦润伟,王齐阳,陈振花,李达翃.Mocetinostat(MGCD 0103)的合成工艺改进[J].中国药物化学杂志,2019,29(6):448-451. 被引量:1
-
2胡森,盛志勇.重视战、创(烧)伤休克现场非常规救治技术研究[J].解放军医学杂志,2011,36(1):5-7. 被引量:9
-
3白慧颖,周国勇,张立俭,胡森.丙戊酸钠对重度烫伤大鼠心肌保护作用及其机制研究[J].中国临床药理学杂志,2011,27(2):130-132. 被引量:8
-
4徐明,赵砚瑾,钱鹏宇,王永珍,李艳阳,谢宁,李庶心.MGCD0103的合成工艺改进[J].中国药物化学杂志,2013,23(4):297-299. 被引量:2
-
5刘昭文,郭小华,曾发挥,杨凯.Mocetinostat的合成研究[J].海峡药学,2019,31(10):64-66.
-
1耿传营(综述),陈文明(审校).组蛋白去乙酰化酶抑制剂治疗血液肿瘤的研究进展[J].国际输血及血液学杂志,2012,35(3):219-223.
-
2吕琳,吴少瑜,饶进军.组蛋白乙酰转移酶和去乙酰化酶的研究[J].现代医院,2008,8(4):1-6. 被引量:6
-
3梁颇,黄旭晴,李万成.组蛋白去乙酰化酶与新生血管形成的关系[J].国际呼吸杂志,2009,29(5):317-320. 被引量:1
-
4王丹丹,何红鹏,张同存.组蛋白乙酰转移酶p300对人乳腺癌细胞迁移的影响[J].天津科技大学学报,2015,30(6):1-6.
-
5史鸿云,李志刚,刘妙玲,祝淑钗,薛桂花,李延红.沉默食管癌ECA109细胞H2AX基因对裸鼠移植瘤放射敏感性的影响[J].中华放射医学与防护杂志,2014,34(11):827-831.
-
6刘源,邬素芳.LSD1与肿瘤相关分子机制的研究进展[J].浙江临床医学,2014,16(7):1168-1170.
-
7耿广勇,汤志刚.组蛋白脱乙酰基酶抑制剂抗肿瘤机制及其临床意义的研究进展[J].肝胆外科杂志,2010,18(1):66-69. 被引量:3
-
8王楠,阎征,刘娜.组蛋白去乙酰酶抑制剂的药理学研究进展[J].中国新药杂志,2004,13(7):594-598. 被引量:2
-
9贾金海,李勇,张晓琳.胃癌前病变内镜活检组织γH2AX蛋白的表达及意义[J].河北医科大学学报,2012,33(3):249-251. 被引量:1
-
10刘鹏,王一理,司履生.组蛋白乙酰化及其与肿瘤的关系[J].中华病理学杂志,2002,31(3):263-265. 被引量:4